Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations

Yu-Chang Wu, David Kipling, Hui Sun Leong, Victoria Martin, Alexander A. Ademokun, Deborah K. Dunn-Walters

Blood (2010) 116 (7): 1070–1078.

https://doi.org/10.1182/blood-2010-03-275859

Published: 2010

Includes: Supplemental data

Journal Articles

One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

Albert Oriol, MD, Pilar Bastida, MD, Olga García, Carlota Calvo, Juan-Manuel Perez-Hurtado, Maria-Elvira González Valentin, Jose Luis Fuster, MD, Izaskun Egurbide, Victoria Martin-Reina, Antonio Molines, MD, Javier Lassaletta, Miguel-Angel Sanz, Mar Tormo, Mercedes Carnero, Juan-José Ortega, Josep-Maria Ribera, MD, PhD

Blood (2009) 114 (22): 2026.

https://doi.org/10.1182/blood.V114.22.2026.2026

Published: 2009

Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial.

Blood (2008) 112 (11): 3291.

https://doi.org/10.1182/blood.V112.11.3291.3291

Published: 2008

Journal Articles

Compassionate Use of Intrathecal Depot Cytarabine (DepoCyte®) in Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma in Spain: Report of 10 Cases.

Juan-Manuel Sancho, MD, Pilar Giraldo, MD, Maria-Jose Romero, MD, Victoria Martin-Reina, MD, Eugenio Gimenez, MD, Elena Ruiz, MD, Plaza Josefa, MD, Carmen Monteserin, MD, Eva Sanchez-Garcia, MD, Rodrigo Martino, MD, Jose Sarra, PhD, Luis Palomera, MD, Josep-Maria Ribera, PhD

Blood (2006) 108 (11): 4518.

https://doi.org/10.1182/blood.V108.11.4518.4518

Published: 2006

Journal Articles

Treatment of Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) with Concurrent Chemotherapy and Imatinib Mesylate.

Josep-Maria Ribera, MD, Albert Oriol, MD, Marcos Gonzalez, MD, Maria-Belen Vidriales, MD, Blanca Xicoy, MD, Javier Grau, MD, Jordi Esteve, MD, Salut Brunet, MD, Eloy Del Potro, MD, Maria-Jose Moreno, MD, Mar Tormo, MD, Maria-Victoria Martin-Reina, MD, Guillermo Deben, MD, Ricardo Parody, MD, Juan-Jose Lahuerta, MD, Jesus-Fernando San Miguel, MD

Blood (2004) 104 (11): 4483.

https://doi.org/10.1182/blood.V104.11.4483.4483

Published: 2004

NARROW

High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations

One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial.

Compassionate Use of Intrathecal Depot Cytarabine (DepoCyte®) in Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma in Spain: Report of 10 Cases.

Treatment of Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) with Concurrent Chemotherapy and Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations

One Year Reinductions with Vincristine, Asparaginase and Prednisone as Post-Remission Therapy Improves Outcome in Children with Intermediate Risk (IR) Acute Lymphoblastic Leukemia (ALL).

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial.

Compassionate Use of Intrathecal Depot Cytarabine (DepoCyte®) in Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma in Spain: Report of 10 Cases.

Treatment of Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) with Concurrent Chemotherapy and Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only